Search

Your search keyword '"Scheipner, Lukas"' showing total 259 results

Search Constraints

Start Over You searched for: Author "Scheipner, Lukas" Remove constraint Author: "Scheipner, Lukas"
259 results on '"Scheipner, Lukas"'

Search Results

1. Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controls

2. Characteristics of incidental prostate cancer in the United States

3. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients

5. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy

8. Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care Therapy

10. In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery

11. Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls

12. Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER Registries

13. Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy

14. Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma Patients

15. Regional differences in clear cell metastatic renal cell carcinoma patients across the USA

16. Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survival

18. Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages

21. Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites

22. Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients

23. Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study

24. ASO Visual Abstract: Prognostic Significance of Pathological Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era

25. ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery

26. Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality–free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients

27. The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm

28. Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma

30. Use of inpatient palliative care in metastatic testicular cancer patients undergoing critical care therapy: insights from the national inpatient sample.

32. Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment

33. Regional differences in upper tract urothelial carcinoma patients across the United States

34. Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients

35. Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients

36. Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites

37. Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion

38. The European Network for the Study of Adrenal Tumors Staging System (2015): A United States Validation.

39. Survival of stage III non‐seminoma testis cancer patients versus simulated controls, according to race/ethnicity.

40. The Effect of Surgical Resection on Cancer-Specific Mortality in Pelvic Soft Tissue Sarcoma According to Histologic Subtype and Stage.

41. Demographic and Clinical Characteristics of Malignant Solitary Fibrous Tumors: A SEER Database Analysis.

42. PD23-06 SURVIVAL DIFFERENCES BETWEEN PHEOCHROMOCYTOMA AND PARAGANGLIOMA PATIENTS

45. MP01-01 INCREMENTAL DOSE-RESPONSE EFFECT OF AGE ON MORTALITY IN NON-SEMINOMA TESTIS CANCER PATIENTS

46. MP38-16 SURVIVAL BENEFIT OF NEPHROURETERECTOMY IN SYSTEMIC THERAPY EXPOSED METASTATIC UPPER TRACT URINARY UROTHELIAL CARCINOMA PATIENTS

47. MP22-07 CONTEMPORARY CONDITIONAL CANCER-SPECIFIC SURVIVAL RATES IN SURGICALLY TREATED NON-METASTATIC PRIMARY URETHRAL CARCINOMA

48. Temporal trends and cancer-specific mortality in non-metastatic muscle-invasive urothelial carcinoma of the urinary bladder treated with trimodal therapy

49. Contemporary conditional cancer‐specific survival rates in surgically treated nonmetastatic primary urethral carcinoma

50. Identifying low cancer‐specific mortality risk lymph node‐positive radical prostatectomy patients

Catalog

Books, media, physical & digital resources